Skip to main content

Home
Specialties
Resources

Search Videos and More

search

Channel Categories

Breast Cancer (6)
Cancer Screening and Survivorship (5)
Cell Therapy (12)
Clinical Trials (14)
Gastrointestinal Cancer (7)
Genitourinary Cancer (6)
Gynecologic Oncology (6)
Head and Neck Cancer (6)
Hematologic Oncology (47)
Immunotherapy (9)
Neuro-Oncology (4)
Pediatric Hematology/Oncology (6)
Primary Care (4)
Radiation Oncology (5)
Skin Cancer (4)
Thoracic Cancer (8)
Young Adult Malignancies (2)

Types

News (47)

Showing 1 - 12 of 47 results

Previous| 1 | 2 | 3 ...4 |Next

Join Roswell Park at AACR 2026

Join Roswell Park at AACR 2026

Clinical Trial Hopes to Boost Survival Rates with Personalized Treatment for Extensive-Stage Small Cell Lung Cancer

Clinical Trial Hopes to Boost Survival Rates with Personalized Treatment for Extensive-Stage Small Cell Lung Cancer

Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference

Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference

Roswell Park at ASH 2025

Roswell Park at ASH 2025

Biomarker-Driven “Umbrella” Study Matches AML, MDS Patients with Specific Clinical Trials

Biomarker-Driven “Umbrella” Study Matches AML, MDS Patients with Specific Clinical Trials

Roswell Park Experts Share Latest Hematology Research at 67th ASH Annual Meeting

Roswell Park Experts Share Latest Hematology Research at 67th ASH Annual Meeting

Roswell Park Experts Host Symposium to Reconnect the “Meaning in Medicine”

Roswell Park Experts Host Symposium to Reconnect the “Meaning in Medicine”

Join Roswell Park Revolutionaries for Cell Therapy Symposium at ASH

Join Roswell Park Revolutionaries for Cell Therapy Symposium at ASH

Myeloma Experts Uncover Key Role for Neutrophils, Potential New Treatment Strategy

Myeloma Experts Uncover Key Role for Neutrophils, Potential New Treatment Strategy

Final Landmark Clinical Trial Data Demonstrates Deep, Durable Responses to Menin Inhibition in Acute Leukemia Patients

Final Landmark Clinical Trial Data Demonstrates Deep, Durable Responses to Menin Inhibition in Acute Leukemia Patients

$Phase 1 Clinical Trial Offers FDA Fast-Tracked Drug for Relapsed/Refractory AML and MDS$ News

Phase 1 Clinical Trial Offers FDA Fast-Tracked Drug for Relapsed/Refractory AML and MDS

Immune Checkpoint Inhibitors ‘High-Risk Yet Promising’ for Cancer Patients Who Undergo Organ Transplant

Immune Checkpoint Inhibitors ‘High-Risk Yet Promising’ for Cancer Patients Who Undergo Organ Transplant

Showing 1 - 12 of 47 results

Previous| 1 | 2 | 3 ...4 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer